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ABSTRACT
AIM: The objective of this study is to evaluate the complications after functional endoscopic sinus surgery 
(FESS) in the Department of Otorhinolaryngology at the St. Marina University Hospital, Varna.
MATERIALS AND METHODS: The records of all patients subjected to FESS were evaluated retrospec-
tively. The complications were classified as major (severe hemorrhage, leakage of cerebral spinal fliud, visu-
al disturbances) and minor (mild hemorrhage, periorbital hematoma and cellulitis, subcutaneous emphy-
sema, epiphora).
RESULTS: The records of all patients subjected to FESS in the time period March 2006 to January 2016 
were retrieved from the digital patient record system of a single institution, St Marina University Hospi-
tal, in Varna, Bulgaria and evaluated retrospectively. A total of 65 patients aged 11-77 (2 children, mean age 
13±2.8 years and 63 adults, mean age 46.5±13.9 years, 41 men and 24 women), who were subjected to FESS, 
were evaluated. Ten cases were classified as minor complications (15.3%). They included subcutaneous em-
physema (n=1, 1.5%) and minimal postoperative bleeding (n=9, 13.8%).  Four cases were classified as major 
complications (6.1%). They included severe hemorrhage, requiring transfusion, nasal packing or rehospital-
ization (n=3, 4.6%), and visual disturbances (n=1, 1.5%).
CONCLUSION: FESS may be considered a relatively safe method with low rate of the complications, but as 
with any surgical intervention, it carries risks. According to other published reports the average rate of mi-
nor and major FESS complications is about 9% and about 0.9%, respectively.
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INTRODUCTION
Functional endoscopic sinus surgery (FESS) is 
a minimally invasive, sophisticated surgical tech-
nique, using an endoscope or microscope to restore 
the drainage and ventilation of the nasal cavity and 
paranasal sinuses. It has been used for over 20 years 
to treat diseases of the nose and the paranasal cav-
ities. The most common indications for FESS are: 
chronic sinusitis refractory to medications and pol-
yps in the nasal cavity (1,2).
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(severe hemorrhage, leakage of cerebral spinal fliud, 
and visual disturbances) and minor (mild hemor-
rhage, periorbital hematoma and cellulitis, subcuta-
neous emphysema, and epiphora). 
RESULTS
A total of 65 patients aged 11-77 (2 children, 
mean age 13±2.8 years and 63 adults, mean age 
46.5±13.9 years, 41 men and 24 women), who were 
Fig. 1. Computed tomography of a patient with 
subcutaneous periorbital emphysema
As with any invasive treatment modality an ex-
tensive list of complications has been reported in the 
literature so far. The major complications associated 
with FESS include severe hemorrhage, leakage of ce-
rebral spinal fliud, and visual disturbances. Exam-
ples of minor complications are mild hemorrhage, 
periorbital hematoma and cellulitis, subcutaneous 
emphysema, and epiphora. Most orbital complica-
tions are classified as major because of the potential 
loss of vision, but orbital emphysema is considered a 
minor complication (2,3). 
AIM
The objective of the present study is to evalu-
ate the complications after FESS in the Department 
of Otorhinolaryngology at the St. Marina University 
Hospital, Varna.
MATERIALS AND METHODS
The records of all patients subjected to FESS in 
the time period March 2006 to January 2016 were re-
trieved from the digital patient record system of a sin-
gle institution, St Marina University Hospital in Var-
na, Bulgaria and evaluated retrospectively (4). With 
regard to patient characteristics, information on pa-
tients’ birth date and examination date was included 
in the file indexing system, and the sex of each pa-
tient was contained in their personal identification 
number. The complications were classified as major 
Fig. 2. A. A patient with anterior and posterior nasal packing. B. Computed tomography of a patient with nasal packing
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subjected to FESS, were evaluated. The indications 
for surgery included nasal polyposis (56.9%, 37/65), 
chronic sinusitis (21.5%, 14/65), polyposis combined 
with sinusitis (9.2%, 6/65), benign tumors (10.7%, 
7/65) and malignant tumors (1.5%, 1/65). The types 
of FESS interventions performed included polypec-
tomy (10.9%), endoscopic incision of multiple sinus-
es (29.6%), combined interventions (48.4%), and ex-
cision/extraction of other lesions (10.9%). Ten cases 
were classified as minor complications (15.3%). They 
included subcutaneous emphysema (n=1, 1.5%), (Fig. 
1) and minimal postoperative bleeding (n=9, 13.8%), 
(Fig. 2A, 2B).  Four cases were classified as major 
complications (6.1%). They included severe hemor-
rhage, requiring transfusion, nasal packing or re-
hospitalization (n=3, 4.6%), and visual disturbances 
(n=1, 1.5%). 
DISCUSSION
FESS is considered a safe and standard method 
for treatment of the nasal and paranasal cavities, but 
the statistics show that complications can occur. Ac-
cording to literature reviews the average rate of mi-
nor complications is between 2.6% (9/260) and 10.5% 
(28/266) (5,6). The complication rate of minimal 
postoperative bleeding is described to be 2% (6/300) 
and the scientific data about cases with subcutane-
ous emphysema is 0.1% (4/3402). (7), (8). The overall 
major complications rate according to published re-
ports is between 0.36% (288/78 944) and 1 % (630/62 
823), including severe hemorrhage requiring trans-
fusion or nasal packing (0.14%, 75/50 734  to 0.76%, 
478/62 823) and orbital injury - 0.07% (45/62 823) to 
0.7% (25/3,402) (1,7,9,10). Sayaka Suzuki et al. report-
ed a rate of 0.02% (12/50 734) for the cases with tox-
ic shock syndrome (1). The literature-based results 
about leakage of cerebral spinal fluid are between 
0.09% (50/50 734) and 0.17% (108/62 823) (1,10).
The results of our group of patients show high-
er complications rate. This may be attributed to the 
surgical experience. Another potential factor may be 
the equipment available. Still, we believe that it is the 
design and the focus of our study that led to this bias. 
We deliberately looked for and analyzed the records 
for any appearance of the word “bleeding”, even if it 
was not considered/coded as a complication at the 
time of discharge or it did not change the clinical and 
ambulatory follow-up of the patient.
In Bulgaria the patients are often being in-
formed that FESS is a “bloodless” intervention, but 
obviously that is not true. The operation carries the 
risk of postoperative bleeding that depends on the 
type and extent of the intervention (polypectomy, tu-
morectomy, FESS for chronic sinusitis). The patients 
should be informed about the eventual postoperative 
complications.
According to the literature review, post-oper-
ative hemorrhages are classified depending on the 
type of bleeding and the moment when they start. 
Depending on the bleeding source the post-operative 
hemorrhage is arterial, capillary, and venous. The 
second classification includes 3 main groups: prima-
ry, reactive, and secondary bleeding. Primary bleed-
ing occurs in the intra-operative period, reactive - in 
the first 24 hours after the operation and the second-
ary - 7-14 days postoperatively. In the group of pa-
tients, who underwent FESS in our institution, there 
were 2 cases with primary and 5 cases with reactive 
bleeding. None of them led to significant change in 
the postoperative follow-up or prolongation of the 
hospital stay.
The most common purpose of nasal packing is 
for bleeding control after surgery of the nasal cavity. 
Nasal packing is done routinely in the majority of the 
patients, who are subjected to FESS. Basha S. I. et al. 
made a retrospective analysis of 110 patients who un-
derwent nasal operations and evaluated the compli-
cation rate when nasal packs were not routinely in-
serted. Nine cases needed nasal packing at the end of 
the surgery and 4 cases - in the postoperative period 
(11). According to our study, all of the patients had 
nasal packing after surgery. The results show that 
one patient needed hemotransfusion and one patient 
needed repacking – both cases with secondary (late) 
bleeding after discharge.
CONCLUSION
FESS may be considered a relatively safe meth-
od with a low rate of complications, but as with any 
surgical intervention, it carries risks. According to 
other published reports the average rate of minor 
complications is about 2.6% to 10.5% and the rate of 
major is about 0.36% to 1% (5,6,9,10). FESS is one of 
the most commonly performed operations in otorhi-
nolaryngology and is generally a safe procedure, but 
major complications may occur.
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